Capital Fund Management S.A. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$29.01 - $74.23 $206,406 - $528,146	-7,115 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$27.51 - $57.29 $195,733 - $407,618	7,115 New	7,115 $242,000
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $441,084 - $583,746	-11,800 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$39.79 - $67.01 $469,522 - $790,718	11,800 New	11,800 $517,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.